Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Flood risk perception, awareness, and preparedness behaviours among vulnerable population groups: implications for building community resilience.

Disasters·2025

Same author

Clindamycin intravenous to oral switch automatic notifications: a pilot study.

Internal medicine journal·2025

Same author

Provision of on-call pharmacist services across public hospitals: a retrospective observational study.

The International journal of pharmacy practice·2025

Same author

Medication shortage behaviour change with multidisciplinary clinician-designed digital notification intervention.

The International journal of pharmacy practice·2024

Same author

Push or pull? Digital notification platform implementation reduces dysglycaemia.

Internal medicine journal·2024

Same author

Translational artificial intelligence-led optimization and realization of estimated discharge with a supportive weekend interprofessional flow team (TAILORED-SWIFT).

Internal and emergency medicine·2024

Search research articles

Related Experiment Video

Updated: Jun 16, 2026

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum

Published on: January 26, 2024

Peritoneal-based malignancies and their treatment.

¹Department of Surgical Oncology, National Cancer Centre of Singapore, Singapore. melteo1@gmail.com

Annals of the Academy of Medicine, Singapore

|February 4, 2010

Summary

Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) offers improved survival for select patients with peritoneal carcinomatosis (PC). This review details the indications, techniques, and outcomes of CRS and HIPEC for peritoneal malignancies.

More Related Videos

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

Related Experiment Videos

Last Updated: Jun 16, 2026

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum

Published on: January 26, 2024

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

Area of Science:

Oncology
Surgical Oncology
Gastroenterology

Background:

Peritoneal carcinomatosis (PC) presents a poor prognosis with traditional systemic therapies.
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are established treatments for specific patients with PC and pseudomyxoma peritonei (PMP).

Purpose of the Study:

To review the indications, technical aspects, morbidity, and mortality associated with CRS and HIPEC.
To identify prognostic factors influencing outcomes in patients undergoing CRS and HIPEC.

Main Methods:

Review of current literature on CRS and HIPEC for peritoneal malignancies.
Analysis of patient selection criteria, including ECOG performance status and absence of extra-abdominal metastases.

Main Results:

CRS and HIPEC are indicated for patients with peritoneal carcinomatosis from colorectal and ovarian cancer, or PMP, without extra-abdominal or liver metastases, and with ECOG performance status <2.
Completeness of resection and biologic factors are crucial prognostic indicators.

Conclusions:

CRS combined with HIPEC can significantly improve survival in carefully selected patients with peritoneal-based malignancies.
Recognizing the specific indications for CRS and HIPEC is vital for optimizing patient outcomes.